CTMXCytomX Therapeutics, Inc.Mar 16, 2026Q4 2025
Read transcript →CytomX Therapeutics, Inc. (CTMX)
NASDAQ·Healthcare·Biotechnology
$4.11
-4.31%
Mkt Cap $757.62M
CTMXCytomX Therapeutics, Inc.Mar 16, 2026CTMXCytomX Therapeutics, Inc.Nov 7, 2025Q3 2025
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 8, 2025Q2 2025
Read transcript →CTMXCytomX Therapeutics, Inc.Mar 6, 2025Q4 2024
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 9, 2024Q2 2024
Read transcript →CTMXCytomX Therapeutics, Inc.May 8, 2024Q1 2024
Read transcript →CTMXCytomX Therapeutics, Inc.Mar 11, 2024Q4 2023
Read transcript →CTMXCytomX Therapeutics, Inc.Nov 8, 2023Q3 2023
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 8, 2023Q2 2023
Read transcript →CTMXCytomX Therapeutics, Inc.May 9, 2023Q1 2023
Read transcript →CTMXCytomX Therapeutics, Inc.Mar 27, 2023Q4 2022
Read transcript →CTMXCytomX Therapeutics, Inc.Nov 8, 2022Q3 2022
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 5, 2022Q2 2022
Read transcript →CTMXCytomX Therapeutics, Inc.May 7, 2022Q1 2022
Read transcript →CTMXCytomX Therapeutics, Inc.Mar 1, 2022Q4 2021
Read transcript →CTMXCytomX Therapeutics, Inc.Nov 7, 2021Q3 2021
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 8, 2021Q2 2021
Read transcript →CTMXCytomX Therapeutics, Inc.May 9, 2021Q1 2021
Read transcript →CTMXCytomX Therapeutics, Inc.Feb 24, 2021Q4 2020
Read transcript →CTMXCytomX Therapeutics, Inc.Nov 7, 2020Q3 2020
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 8, 2020Q2 2020
Read transcript →CTMXCytomX Therapeutics, Inc.May 10, 2020Q1 2020
Read transcript →CTMXCytomX Therapeutics, Inc.Feb 28, 2020Q4 2019
Read transcript →CTMXCytomX Therapeutics, Inc.Nov 7, 2019Q3 2019
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 8, 2019Q2 2019
Read transcript →CTMXCytomX Therapeutics, Inc.May 9, 2019Q1 2019
Read transcript →CTMXCytomX Therapeutics, Inc.Feb 27, 2019Q4 2018
Read transcript →CTMXCytomX Therapeutics, Inc.Nov 11, 2018Q3 2018
Read transcript →CTMXCytomX Therapeutics, Inc.Mar 7, 2018Q4 2017
Read transcript →CTMXCytomX Therapeutics, Inc.Aug 7, 2017Q2 2017
Read transcript →